Willis Towers Watson
Sam Irving currently serves as the Chief Product Officer for Neuron at WTW and is a Newton Fellow in the Newton Venture Program, which aims to enhance diversity in venture capital. Previously, Sam held the position of Head of Innovation & Nile CoFoundry at Nile, collaborating with investors and founders to develop impactful ventures and products. Sam's earlier experience at Lloyd's includes roles such as Digital Channel Lead, where responsibilities included overseeing digital service channel development, and other positions focusing on project management and strategic analysis, contributing significantly to the operational success and technology integration within the Lloyd's Market. Sam holds a degree in Business with International Development from The Open University Business School.
This person is not in any teams
Willis Towers Watson
73 followers
Willis Towers Watson (NASDAQ: WLTW ) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has more than 45,000 employees serving more than 140 countries and markets.